Uzbekistan has announced plans for a Biome center focused on cell technologies, genomics, and biobanking. The project is intended to boost both research and production in key areas of modern biology.
The Center for Advanced Technologies in Uzbekistan already houses the country's first stem cell bank, which stores over 1,200 samples.
The center will focus on cell technologies and genomics, with biobanking as a core component. The goal is to support both academic research and the development of new biotechnologies for practical use.
According to the Academy of Sciences, the Biome project will bring together cell technologies, genomic research, bioinformatics, artificial intelligence, and medical product development. The center will be built on the foundation of the Center for Advanced Technologies. The aim is to create a full-cycle platform, covering everything from collecting samples to clinical applications, as reported by Gazeta.uz.
UzDaily highlights that the Biome center is envisioned as a full-cycle technological platform, covering everything from the collection and study of cellular material to the development of cell-based products and their clinical use. The biobank is set to become a key element of this infrastructure, supporting both research and medical innovation.
Uzbekistan’s investment in the Biome center marks a clear step toward building a research and production ecosystem in bioscience. The country is signaling its intention to play an active role in the next phase of biological innovation. The main challenge will be turning this plan into a working center.
One of the first major projects to be included in the Biome center is the "1000 Genomes of Uzbekistan" initiative, which has collected data from over 1,200 participants and identified about 10 million genetic markers, according to Gazeta.uz. This will make the Biome center a central hub for the country’s genomic data and related research.
The Academy of Sciences has stated that Biome is not just a genetic database, but a full-cycle platform that brings together cell technologies, genomics, and clinical medicine, as noted in a statement to the Tashkent Times.